Seema Bhan
Consultant / Adviseur bij Exai Bio, Inc.
Actieve functies van Seema Bhan
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Exai Bio, Inc.
Exai Bio, Inc. Packaged SoftwareTechnology Services Exai Bio, Inc. is an American next-generation liquid biopsy company founded by Hani Goodarzi, Babak Alipanahi, and Patrick Arensdorf. The company's mission is to enable early detection, accurate diagnosis, personalized and targeted treatment, and ultimately cure of cancer. Exai Bio's proprietary RNA- and AI-based liquid biopsy technology delivers clinical insights into cancer biology to enable the earliest and most accurate diagnosis of cancer. Patrick Arensdorf has been the CEO since incorporation. | Consultant / Adviseur | 02-01-2023 | - |
Section 32 LLC
Section 32 LLC Investment ManagersFinance Section 32 LLC (Section 32) is a venture capital firm founded in 2017 by Bill Maris. The firm is headquartered in Silicon Valley, California. | Consultant / Adviseur | - | - |
Loopbaan van Seema Bhan
Eerdere bekende functies van Seema Bhan
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Thrive Earlier Detection Corp.
Thrive Earlier Detection Corp. Medical SpecialtiesHealth Technology Thrive Earlier Detection Corp. operates as a healthcare company. It focuses on incorporating earlier cancer detection into routine medical care. The company was founded by Bert Vogelstein, Kenneth W. Kinzler, Isaac Kinde, Christoph S. Lengauer, and Nickolas Papadopoulos in 2019 and is headquartered in Cambridge, MA. | Private Equity Investor | 09-01-2019 | 31-01-2023 |
Foundation Medicine GmbH
Foundation Medicine GmbH Miscellaneous Commercial ServicesCommercial Services Part of Roche Holding AG, Foundation Medicine GmbH is a German company that provides technical testing and analysis services. The company is based in Penzberg, Germany. | Private Equity Investor | 01-01-2018 | 30-09-2019 |
Statistieken
Internationaal
Verenigde Staten | 4 |
Duitsland | 2 |
Operationeel
Private Equity Investor | 2 |
Consultant / Advisor | 2 |
Sectoraal
Commercial Services | 2 |
Health Technology | 2 |
Technology Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 4 |
---|---|
Foundation Medicine GmbH
Foundation Medicine GmbH Miscellaneous Commercial ServicesCommercial Services Part of Roche Holding AG, Foundation Medicine GmbH is a German company that provides technical testing and analysis services. The company is based in Penzberg, Germany. | Commercial Services |
Thrive Earlier Detection Corp.
Thrive Earlier Detection Corp. Medical SpecialtiesHealth Technology Thrive Earlier Detection Corp. operates as a healthcare company. It focuses on incorporating earlier cancer detection into routine medical care. The company was founded by Bert Vogelstein, Kenneth W. Kinzler, Isaac Kinde, Christoph S. Lengauer, and Nickolas Papadopoulos in 2019 and is headquartered in Cambridge, MA. | Health Technology |
Exai Bio, Inc.
Exai Bio, Inc. Packaged SoftwareTechnology Services Exai Bio, Inc. is an American next-generation liquid biopsy company founded by Hani Goodarzi, Babak Alipanahi, and Patrick Arensdorf. The company's mission is to enable early detection, accurate diagnosis, personalized and targeted treatment, and ultimately cure of cancer. Exai Bio's proprietary RNA- and AI-based liquid biopsy technology delivers clinical insights into cancer biology to enable the earliest and most accurate diagnosis of cancer. Patrick Arensdorf has been the CEO since incorporation. | Technology Services |
Section 32 LLC
Section 32 LLC Investment ManagersFinance Section 32 LLC (Section 32) is a venture capital firm founded in 2017 by Bill Maris. The firm is headquartered in Silicon Valley, California. | Finance |
- Beurs
- Insiders
- Seema Bhan
- Ervaring